This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
4pod
From Proteopedia
(Difference between revisions)
| Line 3: | Line 3: | ||
<StructureSection load='4pod' size='340' side='right'caption='[[4pod]], [[Resolution|resolution]] 1.99Å' scene=''> | <StructureSection load='4pod' size='340' side='right'caption='[[4pod]], [[Resolution|resolution]] 1.99Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
| - | <table><tr><td colspan='2'>[[4pod]] is a 2 chain structure with sequence from [ | + | <table><tr><td colspan='2'>[[4pod]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4POD OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4POD FirstGlance]. <br> |
| - | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=BR:BROMIDE+ION'>BR</scene>, <scene name='pdbligand=K:POTASSIUM+ION'>K</scene>, <scene name='pdbligand=NA:SODIUM+ION'>NA</scene>, <scene name='pdbligand=PO4:PHOSPHATE+ION'>PO4</scene | + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=BR:BROMIDE+ION'>BR</scene>, <scene name='pdbligand=K:POTASSIUM+ION'>K</scene>, <scene name='pdbligand=NA:SODIUM+ION'>NA</scene>, <scene name='pdbligand=PO4:PHOSPHATE+ION'>PO4</scene></td></tr> |
| - | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4pod FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4pod OCA], [https://pdbe.org/4pod PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4pod RCSB], [https://www.ebi.ac.uk/pdbsum/4pod PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4pod ProSAT]</span></td></tr> | |
| - | + | ||
| - | + | ||
| - | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | + | |
</table> | </table> | ||
== Disease == | == Disease == | ||
| - | [ | + | [https://www.uniprot.org/uniprot/TPIS_HUMAN TPIS_HUMAN] Defects in TPI1 are the cause of triosephosphate isomerase deficiency (TPI deficiency) [MIM:[https://omim.org/entry/190450 190450]. TPI deficiency is an autosomal recessive disorder. It is the most severe clinical disorder of glycolysis. It is associated with neonatal jaundice, chronic hemolytic anemia, progressive neuromuscular dysfunction, cardiomyopathy and increased susceptibility to infection. |
| + | == Function == | ||
| + | [https://www.uniprot.org/uniprot/TPIS_HUMAN TPIS_HUMAN] | ||
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
| Line 23: | Line 22: | ||
==See Also== | ==See Also== | ||
| - | *[[Triose | + | *[[Triose phosphate isomerase 3D structures|Triose phosphate isomerase 3D structures]] |
== References == | == References == | ||
<references/> | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
| - | [[Category: | + | [[Category: Homo sapiens]] |
[[Category: Large Structures]] | [[Category: Large Structures]] | ||
| - | + | [[Category: Amrich CG]] | |
| - | [[Category: Amrich | + | [[Category: Aslam AA]] |
| - | [[Category: Aslam | + | [[Category: Heroux A]] |
| - | [[Category: Heroux | + | [[Category: VanDemark AP]] |
| - | [[Category: VanDemark | + | |
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
Revision as of 07:21, 8 February 2023
Structure of Triosephosphate Isomerase I170V mutant human enzyme.
| |||||||||||
